3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombosis
1
Polycythemia Vera
1
Polycythemia
1
Neoplasms
1
Carcinoma, Squamous Cell
1
Adenocarcinoma
1
Interventions
fludarabine phosphate
5
Cyclophosphamide
4
Whole-Body Irradiation
3
Cyclosporine
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
fludarabine
2
Stem Cell Transplantation
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Methylprednisolone
2
Hydroxyurea
2
Busulfan
2
Antilymphocyte Serum
2
ruxolitinib
1
nelarabine
1
fresolimumab
1
arsenous acid
1
Watchful Waiting
1
Thiotepa
1
Tetradecanoylphorbol Acetate
1
Surveys and Questionnaires
1
RG7388
1
Phlebotomy
1
Oxycodone
1
Observation
1
Nivolumab
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Mycophenolic Acid
1
Moxifloxacin
1
Morphine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Polycythemia Vera
×
Phlebotomy
×
Clear all
NCT01645124
2012-07-20
CYTO-PV
Consorzio Mario Negri Sud
Phase 3
Terminated
365 enrolled